OMCL · Omnicell, Inc.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2026.

The price reported in Column 4 is an exact price of $47.00 for all shares sold.

Shares held in trust with Mr. Lipps' wife.

Represents Restricted Stock Units ("RSUs") granted under the Issuer's equity incentive plan, in connection with Reporting Person's promotion on July 1, 2026. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date.

Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2026.

The price reported in Column 4 is an exact price of $43.22 for all shares sold.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

The price reported in Column 4 is an exact price of $43.22 for all shares sold.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date.

Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date.

Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date.

Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date.

Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

The price reported in Column 4 is an exact price of $34.69 for all shares sold.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 37,409 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 79,494 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).

Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 22,445 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

The price reported in Column 4 is an exact price of $36.59 for all shares sold.

The balance is adjusted to reflect 87.3392 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/26.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

The balance is adjusted to reflect 445.6135 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/26.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

The balance is adjusted to reflect 239.4457 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/26.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

The balance is adjusted to reflect .4503 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/2025 and 532.6238 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/2026.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

The price reported in Column 4 is an exact price of $49.90 for all shares sold.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

The price reported in Column 4 is an exact price of $43.30 for all shares sold.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

The price reported in Column 4 is an exact price of $39.90 for all shares sold.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

The price reported in Column 4 is a weighted average price of $35.9679. The sold price range between $35.65 to $36.4746. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

The options were granted on 2/4/2016 with 25% vested on the one-year anniversary of the grant date and the reaming amount vesting ratably over a 36 month period. The options were fully vested on 2/4/2020.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

The price reported in Column 4 is an exact price of $34.90 for all shares sold.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

The balance is adjusted to reflect 359 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/25.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.

Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on November 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 2/15; (ii) 05/15; (iii) 8/15; and (iv) 11/15.

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.